Physician

Adam Benjamin Katz Cadesky, MD

According to 2025 Medicare claims, Adam Cadesky, MD (NPI: 1528616984) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is SHAKESPEARE OPERATING LLC (NPI: 1720634538; TIN: 84-2678578) and primary practice location at 10455-4670.

Cadesky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 17 traditional Medicare patients, billed 26 HCPCS/CPT codes, and received $2,524 in Medicare payments. Part D data shows 572 prescription claims across 151 beneficiaries totaling $228,153 in drug costs, led by Ozempic (Semaglutide). Open Payments data shows 1 records totaling $62. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $16,946 to $228,153. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3K$2.5K2024 Medicare payment: $2,524 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20241726$2,524

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$114K$228K2019 Drug cost: $16,946 (USD; Tot_Drug_Cst)2020 Drug cost: $13,738 (USD; Tot_Drug_Cst)2021 Drug cost: $20,459 (USD; Tot_Drug_Cst)2022 Drug cost: $19,931 (USD; Tot_Drug_Cst)2023 Drug cost: $120,153 (USD; Tot_Drug_Cst)2024 Drug cost: $228,153 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191328$16,946
202059165$13,738
2021109303$20,459
202267199$19,931
202351253$120,153
2024151572$228,153

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide642,710$80,289
MounjaroTirzepatide401,188$42,223
JanuviaSitagliptin Phosphate251,350$23,808
JardianceEmpagliflozin19930$17,616
TrulicityDulaglutide11364$12,098

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$62Novo Nordisk Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Benjamin Katz Cadesky, MD?

Tedicare shows public-source Medicare data for Adam Benjamin Katz Cadesky, MD (NPI 1528616984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Benjamin Katz Cadesky, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Benjamin Katz Cadesky, MD?

Adam Benjamin Katz Cadesky, MD is linked to SHAKESPEARE OPERATING LLC (billing NPI 1720634538) in the available physician profile data.

Does Adam Benjamin Katz Cadesky, MD have Open Payments data?

Adam Benjamin Katz Cadesky, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.